This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2d31

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2d31" size="450" color="white" frame="true" align="right" spinBox="true" caption="2d31, resolution 3.20&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:2d31.gif|left|200px]]<br />
+
[[Image:2d31.gif|left|200px]]<br /><applet load="2d31" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2d31" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2d31, resolution 3.20&Aring;" />
caption="2d31, resolution 3.20&Aring;" />
'''Crystal structure of disulfide-linked HLA-G dimer'''<br />
'''Crystal structure of disulfide-linked HLA-G dimer'''<br />
==Overview==
==Overview==
-
HLA-G is a nonclassical major histocompatibility complex class I (MHCI), molecule, which is expressed in trophoblasts and confers immunological, tolerance in the maternal-fetal interface by binding to leukocyte Ig-like, receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed, in disulfide-linked dimer form both in solution and at the cell surface., Interestingly, MHCI dimer formations have been involved in pathogenesis, and T cell activation. The structure and receptor binding characteristics, of MHCI dimers have never been evaluated. Here we performed binding, studies showing that the HLA-G dimer exhibited higher overall affinity to, LILRB1/2 than the monomer by significant avidity effects. Furthermore, the, cell reporter assay demonstrated that the dimer formation remarkably, enhanced the LILRB1-mediated signaling at the cellular level. We further, determined the crystal structure of the wild-type dimer of HLA-G with the, intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed, the oblique configuration to expose two LILR/CD8-binding sites upward from, the membrane easily accessible for receptors, providing plausible 1:2, (HLA-G dimer:receptors) complex models. These results indicated that the, HLA-G dimer conferred increased avidity in a proper structural orientation, to induce efficient LILR signaling, resulting in the dominant, immunosuppressive effects. Moreover, structural and functional, implications for other MHCI dimers observed in activated T cells and the, pathogenic allele, HLA-B27, are discussed.
+
HLA-G is a nonclassical major histocompatibility complex class I (MHCI) molecule, which is expressed in trophoblasts and confers immunological tolerance in the maternal-fetal interface by binding to leukocyte Ig-like receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed in disulfide-linked dimer form both in solution and at the cell surface. Interestingly, MHCI dimer formations have been involved in pathogenesis and T cell activation. The structure and receptor binding characteristics of MHCI dimers have never been evaluated. Here we performed binding studies showing that the HLA-G dimer exhibited higher overall affinity to LILRB1/2 than the monomer by significant avidity effects. Furthermore, the cell reporter assay demonstrated that the dimer formation remarkably enhanced the LILRB1-mediated signaling at the cellular level. We further determined the crystal structure of the wild-type dimer of HLA-G with the intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed the oblique configuration to expose two LILR/CD8-binding sites upward from the membrane easily accessible for receptors, providing plausible 1:2 (HLA-G dimer:receptors) complex models. These results indicated that the HLA-G dimer conferred increased avidity in a proper structural orientation to induce efficient LILR signaling, resulting in the dominant immunosuppressive effects. Moreover, structural and functional implications for other MHCI dimers observed in activated T cells and the pathogenic allele, HLA-B27, are discussed.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
2D31 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2D31 OCA].
+
2D31 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2D31 OCA].
==Reference==
==Reference==
Line 29: Line 28:
[[Category: mhc class i]]
[[Category: mhc class i]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:25:45 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:54:51 2008''

Revision as of 14:54, 21 February 2008


2d31, resolution 3.20Å

Drag the structure with the mouse to rotate

Crystal structure of disulfide-linked HLA-G dimer

Contents

Overview

HLA-G is a nonclassical major histocompatibility complex class I (MHCI) molecule, which is expressed in trophoblasts and confers immunological tolerance in the maternal-fetal interface by binding to leukocyte Ig-like receptors (LILRs, also called as LIR/ILT/CD85) and CD8. HLA-G is expressed in disulfide-linked dimer form both in solution and at the cell surface. Interestingly, MHCI dimer formations have been involved in pathogenesis and T cell activation. The structure and receptor binding characteristics of MHCI dimers have never been evaluated. Here we performed binding studies showing that the HLA-G dimer exhibited higher overall affinity to LILRB1/2 than the monomer by significant avidity effects. Furthermore, the cell reporter assay demonstrated that the dimer formation remarkably enhanced the LILRB1-mediated signaling at the cellular level. We further determined the crystal structure of the wild-type dimer of HLA-G with the intermolecular Cys(42)-Cys(42) disulfide bond. This dimer structure showed the oblique configuration to expose two LILR/CD8-binding sites upward from the membrane easily accessible for receptors, providing plausible 1:2 (HLA-G dimer:receptors) complex models. These results indicated that the HLA-G dimer conferred increased avidity in a proper structural orientation to induce efficient LILR signaling, resulting in the dominant immunosuppressive effects. Moreover, structural and functional implications for other MHCI dimers observed in activated T cells and the pathogenic allele, HLA-B27, are discussed.

Disease

Known diseases associated with this structure: Asthma, susceptibility to OMIM:[142871], Hypoproteinemia, hypercatabolic OMIM:[109700]

About this Structure

2D31 is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer., Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, Tsumoto K, Kumagai I, Kohda D, Maenaka K, J Biol Chem. 2006 Apr 14;281(15):10439-47. Epub 2006 Feb 2. PMID:16455647

Page seeded by OCA on Thu Feb 21 16:54:51 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools